在2010-2024年期间驱动抗体和流感病毒进化
Xiuhua Lu1, Feng Liu1, Wen-Pin Tzeng1
1Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Open forum infectious diseases
|August 20, 2025
概括
血液凝聚抑制抗体免疫主导性 (HAI- Ab- ID) 在成年人中很常见,并驱动流感病毒的演变. 监测HAI- Ab- ID和病毒变化对于提高流感疫苗的有效性至关重要.
科学领域:
- 免疫学
- 病毒学
- 流行病学
背景情况:
- 对于预测流感病毒抗原漂移来说,了解血液凝结抑制抗体免疫主导性 (HAI- Ab- ID) 是至关重要的.
- 这项研究调查了用A/California/07/2009类 (CA/09) 疫苗接种的成年人的表位特异性HAI-Ab-ID,并检查了A(H1N1) pdm09病毒演变.
研究的目的:
- 在用CA/09疫苗免疫成年人中探索表位特异性HAI- Ab- ID.
- 分析与HAI-Ab-ID相关的A(H1N1) pdm09病毒的演变.
主要方法:
- 使用HAI检测分析了300名成年人的血清 (2010-2016).
- 使用逆遗传病毒和历史的A(H1N1) 菌株来确定表位特异的HAI-Ab-ID.
- 使用抗体吸附试验和GISAID序列数据来验证特异性和分析病毒演变.
主要成果:
- 四种针对特定表位的HAI-Ab-ID在>50%的捐赠者中流行 (2010年至2016年).
- 交叉反应的HAI-Ab-ID转变为菌株特异的,免疫选择压力导致逃生突变的固定.
- 三种逃生突变 (K163Q,N129D,K130N) 在特定的季节变得固定的.
结论:
- HAI- Ab- IDs是常见的,并显著影响流感病毒和抗体的演变.
- 这些变化的关键驱动因素是HAI-Ab介导的免疫选择和抑制.
- 持续监测病毒和HAI- Ab- ID的演变对于提高流感疫苗的有效性至关重要.
相关概念视频
Viral Mutations
32.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.8K
Affinity and Avidity
36.6K
Overview
36.6K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Cross-reactivity
31.5K
Overview
31.5K


